CureVac has accused Pfizer and BioNTech of infringing its patents, including the patents at issue in the Acuitas case, in an ongoing lawsuit in Virginia. The case is Acuitas Therapeutics Inc v.
Acuitas Therapeutics settles lawsuit with CureVac over COVID-19 vaccine patents. Legal disputes unfold among biotech giants Pfizer, BioNTech, and CureVac, as GSK joins the fray, alleging patent ...
CureVac and Acuitas Therapeutics have settled their COVID-19 vaccine dispute. According to a filing, submitted April 25, 2024 ...
GSK said in the lawsuit , opens new tab that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed "more than a decade before" the ...
However, a lawsuit filed in February 2023 claims that the products not only don’t live up to their hype—they are actively dangerous. Here’s what you need to know about the Olaplex lawsuit.
CureVac shares are trading lower after the company announced a proposed public offering of common stock.
Shares of biopharmaceutical company CureVac touched a new low on Wednesday following news the company, together with GSK, ended a pandemic agreement with Germany and will implement an ...
enables progressing to Part B with expected start mid-2024 CureVac to host conference call and webcast today at 9 a.m. ET / 3 p.m. CET TÜBINGEN, GERMANY and HOUSTON, TX / ACCESSWIRE / April 24 ...
Child sexual abuse at Illinois juvenile detention centers was pervasive and systemic for decades, according to disturbing accounts in a lawsuit filed Monday by 95 men and women housed at the youth ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Benzinga - by Vandana Singh, Benzinga Editor. Canadian Biotech company Acuitas Therapeutics and Germany-based CureVac NV (NASDAQ:CVAC) have settled Acuitas’ lawsuit over credit for inventions tied to ...